ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Exploring Cognitive Dysfunction in Rheumatology

Ruth Jessen Hickman, MD  |  November 17, 2025

“One of the most powerful things we could do is to really validate patients’ experience and acknowledge that brain fog is real and help them to feel supported,” said Dr. Chen.

“Often brain fog is dismissed as laziness, depression or aging,” said Ms. Alore. “I ask you to create a safe space for patients to discuss any cognitive challenges that they may be experiencing.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Ruth Jessen Hickman, MD, a graduate of the Indiana University School of Medicine, is a medical and science writer in Bloomington, Ind.

References

  1. Oláh C, Schwartz N, Denton C, et al. Cognitive dysfunction in autoimmune rheumatic diseases. Arthritis Res Ther. 2020 Apr 15;22(1):78.
  2. Kratz AL, Whibley D, Kim S, et al. Fibrofog in daily life: An examination of ambulatory subjective and objective cognitive function in fibromyalgia. Arthritis Care Res (Hoboken). 2020 Dec;72(12):1669–1677.
  3. Whibley D, Williams DA, Clauw DJ, et al. Within-day rhythms of pain and cognitive function in people with and without fibromyalgia: Synchronous or syncopated? Pain. 2022 Mar 1;163(3):474–482.
  4. Meade T, Manolios N, Cumming SR, et al. Cognitive impairment in rheumatoid arthritis: A systematic review. Arthritis Care Res (Hoboken). 2018 Jan;70(1):39–52.
  5. McDowell B, Marr C, Holmes C, et al. Prevalence of cognitive impairment in patients with rheumatoid arthritis: A cross sectional study. BMC Psychiatry. 2022 Dec 9;22(1):777.
  6. Vitturi BK, Nascimento BAC, Alves BR, et al. Cognitive impairment in patients with rheumatoid arthritis. J Clin Neurosci. 2019 Nov;69:81–87. 
  7. Shin SY, Katz P, Wallhagen M, Julian L. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 Aug;64(8):1144–1150.
  8. Pankowski D, Wytrychiewicz-Pankowska K, Janowski K, Pisula E. Cognitive impairment in patients with rheumatoid arthritis: A systematic review and meta-analysis. Joint Bone Spine. 2022 May;89(3):105298.
  9. Appenzeller S, Bertolo MB, Costallat LT. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol. 2004 Jun;26(5):339–343.
  10. Chen YT, Lescoat A, Devine A, et al. Cognitive difficulties in people with systemic sclerosis: A qualitative study. Rheumatology (Oxford). 2022 Aug 30;61(9):3754–3765.
  11. Amaral TN, Peres FA, Lapa AT, et al. FRI0488 prevalence and clinical significance of cognitive impairment in systemic sclerosis. Ann Rheum Dis. 2015;74(Supp 2):605.
  12. Chen YT, Lescoat A, Khanna D, Murphy SL. Perceived cognitive function in people with systemic sclerosis: Associations with symptoms and daily life functioning. Arthritis Care Res (Hoboken). 2023 Aug;75(8):1706–1714.
  13. Khedr EM, El Fetoh NA, Gamal RM, et al. Evaluation of cognitive function in systemic sclerosis patients: A pilot study. Clin Rheumatol. 2020;39:1551–1559.
  14. National Institutes of Health. Brain Boost Program to improve cognitive function in people with systemic sclerosis. https://www.clinicaltrials.gov/study/NCT06880627.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAcognitive dysfunctionFibromyalgiaRheumatoid arthritisScleroderma

Related Articles

    Revising Fibromyalgia: One Year Later

    July 12, 2011

    The 2010 ACR fibromyalgia criteria capture the broader clinical picture and help ensure more appropriate diagnosis and management by primary care

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Lupus in the Child’s Mind

    March 1, 2009

    Unique neuropsychiatric problems require a unique approach

    Pinpoint Cognitive Dysfunction in Patients with Lupus

    April 6, 2012

    More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences